Full-Time

Director – Human Resources Business Partner

Posted on 10/8/2024

Verve Therapeutics

Verve Therapeutics

201-500 employees

Develops gene editing therapies for cardiovascular disease

Biotechnology
Healthcare

Senior

No H1B Sponsorship

Boston, MA, USA

Hybrid role requiring 3 days in the Boston office.

Category
Human Resources
People & HR
Requirements
  • B.S. in Business, Management, Human Resources, or related field with 10+ years of progressive Human Resources experience.
  • Previous biotech experience is required.
  • Experience with a high growth organization.
  • Exceptional communicator, influencer, and relationship-builder.
  • Proven track record of handling a variety of employee relations issues with a solid understanding of employment law.
  • Exceptional judgment and integrity when making decisions, always considering the bigger picture.
  • Strong analytical skills and ability to use metrics to drive decisions.
  • Ability to work as part of collaborative HR team.
  • Attention to detail is a must.
Responsibilities
  • Build and cultivate strong partnerships with leaders and managers to offer thought leadership on organizational and people-related strategy ensuring a high-performing and engaged workforce.
  • Lead the planning and execution of cultural and diversity, equity, and inclusion initiatives and ensure pull-through into our HR processes.
  • Partner with client groups on organizational design and workforce planning to scale the organization for future growth, applying past experience to anticipate potential organizational challenges.
  • Collaborate with hiring managers and Talent Acquisition to develop job descriptions and support strong talent identification and integration.
  • Lead or collaborate in building or enhancing and driving successful rollout of key HR programs including workforce planning, talent review, performance management, promotion process, compensation planning, and employee engagement. Analyze data and prepare presentations for various audiences.
  • Work closely with both management and employees to improve work relationships, build morale, and increase productivity and retention.
  • Facilitate employee relations in a positive, fair, and proactive manner with exceptional judgement.
  • Support teams in understanding and digesting employee feedback and partner on initiatives to strengthen team culture.
  • Facilitate new-hire check-ins and departing employee exit interviews, synthesize themes, diagnose root causes, and provide recommendations to leadership.
  • Other special projects and duties as assigned.

Verve Therapeutics focuses on developing gene editing therapies to treat cardiovascular disease. Their approach involves creating single-course treatments that aim to provide lasting solutions rather than ongoing management. The company specifically targets the PCSK9 and ANGPTL3 genes, which are known to help lower blood lipid levels. This focus on gene editing sets Verve apart from traditional therapies that require continuous treatment. The goal of Verve Therapeutics is to offer potentially curative options for patients with cardiovascular conditions, improving their long-term health outcomes.

Company Stage

IPO

Total Funding

$353.6M

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

33%
Simplify Jobs

Simplify's Take

What believers are saying

  • Eli Lilly's $60M investment indicates strong market interest in Verve's therapies.
  • CRISPR-based therapy successes suggest a favorable regulatory environment for Verve.
  • Strategic partnerships with large pharma can accelerate Verve's development and commercialization.

What critics are saying

  • Potential competition from Vertex and CRISPR Therapeutics could overshadow Verve's advancements.
  • Most CRISPR therapies are in early stages, delaying Verve's path to approval.
  • Recent stock price drop may reflect investor concerns about Verve's financial stability.

What makes Verve Therapeutics unique

  • Verve Therapeutics focuses on single-course gene editing for cardiovascular diseases.
  • The company targets well-validated genes PCSK9 and ANGPTL3 for lipid lowering.
  • Verve's approach shifts treatment from chronic management to potentially curative solutions.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE